Article info
PDFFeatured Posters: Poster Rounds with the Professors
AS04. Endometrial/Uterine corpus cancers
PR040/#109 Metformin as an adjunct to progestin therapy in endometrial hyperplasia and early-stage endometrial cancer: a systematic review and meta-analysis of randomized controlled trials
Citation
PR040/#109 Metformin as an adjunct to progestin therapy in endometrial hyperplasia and early-stage endometrial cancer: a systematic review and meta-analysis of randomized controlled trials
Publication history
- First published November 7, 2023.
Online issue publication
November 07, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.